The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
iopamidol
iopamidol · IOPAMIDOL 408 mg/mL · Injection, Solution · Intrathecal · Slate Run Pharmaceuticals, LLC
NDC 70436-0124-82 · 100 mL in 1 CARTON · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$300.00
Reported to Texas DSHS · 2025 annual filing · Slate Run Pharmaceuticals, LLC.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1 ML
$0.435
HCPCS Q9966 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$10
53 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA215382
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of iopamidol (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bracco Diagnostics Inc | IOPAMIDOL 612 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Slate Run Pharmaceuticals, LLC | IOPAMIDOL 408 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Slate Run Pharmaceuticals, LLC | IOPAMIDOL 612 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 755 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 408 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 612 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 510 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 408 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 755 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Italia S.p.A. | IOPAMIDOL 408 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Italia S.p.A. | IOPAMIDOL 510 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Italia S.p.A. | IOPAMIDOL 612 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Italia S.p.A. | IOPAMIDOL 755 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals, LLC | IOPAMIDOL 510 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals, LLC | IOPAMIDOL 755 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals | IOPAMIDOL 612 mg/mL | Jul 15, 2026 | Jul 29, 2026 |
| Slate Run Pharmaceuticals | IOPAMIDOL 408 mg/mL | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "iopamidol — NDC 70436-0124-82," retrieved September 3, 2026, https://drugdashboards.com/drug/70436012482.
Free to cite with attribution — see how the data is put together.